Related Experiment Videos
MR imaging and heart function in patients pre- and post-Fontan surgery
1Department of Radiology, Children's Hospital of Philadelphia, PA, USA.
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|August 1, 1995
Summary
Magnetic Resonance (MR) imaging offers 3D cardiac evaluation, assessing ventricular function regardless of chamber size. Post-Fontan operation children show reduced ventricular volumes and cardiac indices, potentially predicting outcomes.
Area of Science:
- Cardiovascular Imaging
- Pediatric Cardiology
- Cardiac Surgery
Background:
- Three-dimensional Magnetic Resonance (MR) imaging provides comprehensive cardiac functional evaluation.
- The Fontan operation is a complex multi-stage surgical procedure for single-ventricle congenital heart defects.
- Assessing ventricular function post-Fontan operation is crucial for patient management.
Purpose of the Study:
- To evaluate ventricular volumes, mass, and cardiac indices in children following multi-staged Fontan operations using MR imaging.
- To determine if observed variations in ventricular function are predictive of long-term outcomes in post-Fontan patients.
Main Methods:
- Utilized three-dimensional MR imaging for volumetric and functional assessment of cardiac ventricles.
- Applied standard measurement techniques to quantify ventricular volumes, mass, and cardiac indices.
- Analyzed data from pediatric patients who have undergone multi-staged Fontan procedures.
Main Results:
- Demonstrated diminished ventricular volumes and mass in children post-Fontan operation.
- Observed decreased cardiac indices in the post-Fontan cohort compared to normative values.
- Identified potential correlations between functional variations and patient outcomes.
Conclusions:
- Three-dimensional MR imaging is a reliable tool for assessing cardiac function in complex post-surgical pediatric populations.
- Post-Fontan operation is associated with significant alterations in ventricular size and function.
- These functional changes may serve as important predictors for the clinical trajectory of Fontan survivors.